Vietnam Prediabetes Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Vietnam Prediabetes Market Overview

• The Vietnam Prediabetes Market is valued at USD 1.3 billion, based on a five-year historical analysis of expenditure on diabetes drugs, diabetes care devices, preventive screening, and associated lifestyle intervention services in Vietnam. This growth is primarily driven by the increasing prevalence of obesity, sedentary lifestyles, and rising awareness about diabetes management among the population. The healthcare sector's focus on preventive measures and early diagnosis, supported by expanded screening and insurance coverage for diabetes-related services, has also contributed significantly to the market's expansion.
• Key urban centers such as Ho Chi Minh City and Hanoi dominate the market due to their large populations, higher diabetes prevalence, and advanced healthcare infrastructure. These cities have seen a surge in hospitals, specialty endocrinology clinics, diagnostic centers, and wellness programs, making them focal points for diabetes management and prediabetes interventions. The concentration of healthcare resources, employer-sponsored screening initiatives, and educational campaigns in these areas further enhances their market dominance.
• The Vietnamese government has progressively integrated diabetes and prediabetes prevention into national noncommunicable disease strategies, with coordinated programs aimed at early detection and lifestyle modification in primary care. Under the National Strategy on Prevention and Control of Noncommunicable Diseases and the National Health Target Programs led by the Ministry of Health, nationwide activities include public awareness campaigns, risk?based screening at commune health stations, and collaboration with hospitals and social organizations to promote diet and physical activity changes among at?risk populations.

Vietnam Prediabetes Market Segmentation

By Prediabetes Type:The prediabetes market is segmented into various types, including Impaired Fasting Glucose (IFG), Impaired Glucose Tolerance (IGT), Combined IFG and IGT, Gestational Prediabetes Risk, and Others. This segmentation is aligned with clinical practice and diagnostic criteria commonly applied in Vietnam for individuals at high risk of type 2 diabetes. Among these, Impaired Fasting Glucose (IFG) is the leading subsegment, driven by the increasing number of individuals diagnosed with elevated fasting glucose levels through routine and opportunistic screenings in primary care and workplace programs. The growing awareness of the health risks associated with prediabetes, supported by campaigns from the Ministry of Health and professional associations, has led to more people seeking testing and intervention, thereby boosting the demand for services targeting IFG.

By Intervention Type:The market is also segmented by intervention types, including Lifestyle Modification Programs, Pharmacological Interventions, Digital & Remote Coaching Solutions, Community & Workplace Wellness Programs, and Others. Lifestyle Modification Programs are currently the most dominant segment, as they encompass a holistic approach to managing prediabetes through diet, exercise, and counseling, which aligns with international and national clinical guidelines prioritizing non?pharmacological management as first?line therapy for high?risk individuals. The increasing focus on preventive healthcare, growth in organized wellness and fitness services in major cities, and the demonstrated effectiveness of lifestyle changes in delaying or reversing progression from prediabetes to diabetes have made this segment particularly appealing to both healthcare providers and patients.

Vietnam Prediabetes Market Competitive Landscape

The Vietnam Prediabetes Market is characterized by a dynamic mix of regional and international players. Leading participants such as Vinmec Healthcare System, Hoan My Medical Corporation, FV Hospital, Hanoi Medical University Hospital, Vingroup Joint Stock Company (Vingroup JSC), Nutifood Nutrition Food JSC, Abbott Laboratories, Roche Diagnostics, Bayer AG, Johnson & Johnson, Medtronic plc, Sanofi S.A., Novo Nordisk A/S, Merck & Co., Inc., Eli Lilly and Company contribute to innovation, geographic expansion, and service delivery in this space.

Vietnam Prediabetes Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Obesity:The World Health Organization reported that Vietnam's obesity rate has surged to18.3 million adultsin the future, a significant increase from15.5 million in the past. This rise correlates with a sedentary lifestyle, where60%of the population engages in insufficient physical activity. The growing obesity rates are directly linked to an increased risk of prediabetes, driving demand for preventive healthcare solutions and management programs.
• Rising Awareness about Health and Wellness:In the future, approximately70%of Vietnamese adults are expected to prioritize health and wellness, reflecting a cultural shift towards preventive care. This trend is supported by a30%increase in health-related online searches and a25%rise in participation in wellness programs. As awareness grows, more individuals are seeking screening and management options for prediabetes, thus expanding the market for related healthcare services.
• Government Initiatives Promoting Diabetes Prevention:The Vietnamese government has allocatedUSD 50 millionfor diabetes prevention programs in the future, aiming to reduce the prevalence of diabetes by20%by a specified future date. This initiative includes public health campaigns and subsidized screenings, which are expected to increase the number of individuals diagnosed with prediabetes. Such proactive measures are crucial in fostering a healthier population and stimulating market growth for diabetes management solutions.

Market Challenges

• Limited Access to Healthcare Facilities:Approximately70%of Vietnam's rural population lacks access to adequate healthcare facilities, which poses a significant barrier to diabetes screening and management. The World Bank indicates that only30%of rural health centers are equipped to handle chronic diseases, leading to underdiagnosis and inadequate treatment of prediabetes. This challenge hampers the overall effectiveness of diabetes prevention initiatives in rural areas.
• High Cost of Diabetes Management Solutions:The average annual cost of diabetes management in Vietnam is aroundUSD 1,200, which is prohibitive for many individuals, especially in lower-income brackets. With over25%of the population living below the poverty line, the financial burden of diabetes care limits access to necessary treatments and preventive measures. This economic barrier significantly impacts the market's growth potential and patient outcomes.

Vietnam Prediabetes Market Future Outlook

The Vietnam prediabetes market is poised for significant transformation as the government intensifies its focus on preventive healthcare and public awareness campaigns. With the integration of digital health solutions and telemedicine, access to diabetes management resources is expected to improve, particularly in underserved areas. Additionally, the rise of personalized medicine approaches will likely enhance treatment efficacy, catering to the unique needs of individuals at risk of developing diabetes. These trends will shape a more proactive healthcare landscape in Vietnam.

Market Opportunities

• Growth of Telemedicine and Digital Health Solutions:The telemedicine market in Vietnam is projected to reachUSD 1 billionby a specified future date, driven by increased smartphone penetration and internet access. This growth presents an opportunity for remote diabetes management solutions, enabling patients to receive timely care and education, thus improving health outcomes and reducing the burden on healthcare facilities.
• Expansion of Health Insurance Coverage:The Vietnamese government aims to increase health insurance coverage to90%of the population by a specified future date. This expansion will facilitate access to diabetes screening and management services, making it more affordable for individuals to seek preventive care. As insurance coverage grows, the market for diabetes-related healthcare services is expected to expand significantly.